ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

HU

Hospital Universitario Puerta de Hierro Majadahonda at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitario Puerta de Hierro Majadahonda takes part in 18 sessions at ESMO 2026 in Madrid. Its program spans lung, ovarian, breast, and cervical cancers, alongside care access and patient wellbeing. Topics include treatment options for advanced lung cancer and exercise and heart-risk management after early breast cancer.

OrganizationESMO 2026 Attendance
HU
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain
Cancer centre & hospital
Public university hospital of the Madrid regional health service in Majadahonda, Spain, and a teaching hospital of the Autonomous University of Madrid.
Satellite
Fri Oct 23
09:45–11:15
Satellite
Fri Oct 23
09:45–11:15
Bristol Myers Squibb - Optimizing the NSCLC Treatment Landscape: Impact for Today and Insights for Tomorrow
with European Institute of Oncology (IEO), Vall d'Hebron University Hospital
Lung & thoracic cancers
Satellite
Fri Oct 23
09:45–10:00
New Currents, New Directions: The Evolving Ovarian Cancer Treatment Paradigm
AbbVie - Riding the Wave of Innovation Towards Personalized Medicine in Ovarian Cancer
Gynaecological cancers
Satellite
Fri Oct 23
09:45–09:50
Welcome and Introductions
Bristol Myers Squibb - Optimizing the NSCLC Treatment Landscape: Impact for Today and Insights for Tomorrow
Lung & thoracic cancers
Satellite
Fri Oct 23
09:50–10:10
Exploring the Many Faces of NSCLC Management
Bristol Myers Squibb - Optimizing the NSCLC Treatment Landscape: Impact for Today and Insights for Tomorrow
Lung & thoracic cancers
Satellite
Fri Oct 23
10:50–11:10
Keeping the Patient in the Center
Bristol Myers Squibb - Optimizing the NSCLC Treatment Landscape: Impact for Today and Insights for Tomorrow · with International Cancer Advocacy Network (ICAN), European Institute of Oncology (IEO), Vall d'Hebron University Hospital
Lung & thoracic cancers
Poster
Fri Oct 23
13:00–15:00
A scoping review of shared decision-making in patients with advanced colorectal cancer
ePoster session 5
Gastrointestinal cancersNursing & supportive care
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
16:15–17:30
Optimising use of local therapy in advanced lung cancer: Why, when, and how
with Guangdong Provincial People's Hospital
Lung & thoracic cancers
Talk
Fri Oct 23
16:20–16:40
Medical oncology perspective
Optimising use of local therapy in advanced lung cancer: Why, when, and how
Lung & thoracic cancers
Poster
Sat Oct 24
12:00–12:45
Satellite
Sat Oct 24
13:00–14:30
Satellite
Sat Oct 24
13:00–13:15
The Evolving Landscape in Endometrial and Ovarian Cancers
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care
Gynaecological cancers
Satellite
Sat Oct 24
13:15–13:20
Audience polling
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care · with Centre Léon Bérard, University of California San Diego
Gynaecological cancers
Talk
Sun Oct 25
10:30–10:45
Financial toxicity and equity (access to treatment)
Equitable health care of underserved population
Nursing & supportive care
Poster
Sun Oct 25
12:00–12:45
Impact of residential radon exposure on the molecular profile of lung cancer in Spain: Results from the RTT-ATLAS-Radon study
Sunday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Satellite
Sun Oct 25
13:00–14:30
Satellite
Sun Oct 25
13:00–13:05
Welcome and Introductions
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with University of Turin
Lung & thoracic cancers
Satellite
Sun Oct 25
13:05–13:20
What We Know and Don’t Know About Immunotherapy in Resectable NSCLC
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease
Lung & thoracic cancers
Satellite
Sun Oct 25
13:20–14:05
Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with University Hospital Cologne, Trinity St James's Cancer Institute, University of Turin +1 more
Lung & thoracic cancers
Satellite
Sun Oct 25
14:25–14:30
Close
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with University of Turin
Lung & thoracic cancers
Chair
Sun Oct 25
14:45–16:15
Cervical cancer: From prevention to optimal therapy
with Medical University of Innsbruck
Gynaecological cancers
Talk
Sun Oct 25
15:25–15:45
Optimal systemic therapy for persistent, recurrent or metastatic disease
Cervical cancer: From prevention to optimal therapy
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
Poster
Mon Oct 26
12:00–12:45
Patterns and outcomes of relapse in DLBCL: Real-world data from the national GOTEL registry
Monday Poster Display session 2
Haematological malignancies

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital Universitario Puerta de Hierro Majadahonda

Tell us what you sell and we’ll find the people at Hospital Universitario Puerta de Hierro Majadahonda most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction